Huntington disease stems from a mutation of the protein huntingtin and is characterized by selective loss of discrete neuronal populations in the brain. Despite a massive loss of neurons in the corpus striatum, NO-generating neurons are intact. We recently identified a brain-specific protein that associates with huntingtin and is designated huntingtinassociated protein (HAPI). We now describe selective neuronal localizations of HAPI. In situ hybridization studies reveal a resemblance of HAPI and neuronal nitric oxide synthase (nNOS) mRNA localizations with dramatic enrichment of both in the pedunculopontine nuclei, the accessory olfactory bulb, and the supraoptic nucleus of the hypothalamus. Both nNOS and HAPI are enriched in subcellular fractions containing synaptic vesicles. Immunocytochemical studies indicate colocalizations of HAP1 and nNOS in some neurons. The
rons are intact. We recently identified a brain-specific protein that associates with huntingtin and is designated huntingtinassociated protein (HAPI). We now describe selective neuronal localizations of HAPI. In situ hybridization studies reveal a resemblance of HAPI and neuronal nitric oxide synthase (nNOS) mRNA localizations with dramatic enrichment of both in the pedunculopontine nuclei, the accessory olfactory bulb, and the supraoptic nucleus of the hypothalamus. Both nNOS and HAPI are enriched in subcellular fractions containing synaptic vesicles. Immunocytochemical studies indicate colocalizations of HAP1 and nNOS in some neurons. The possible relationship of HAP1 and nNOS in the brain is reminiscent of the relationship of dystrophin and nNOS in skeletal muscle and suggests a role of NO in Huntington disease, analogous to its postulated role in Duchenne muscular dystrophy.
Huntington disease (HD) is an autosomal dominant neurodegenerative disease characterized by massive neuronal loss in some brain regions, while certain neuronal populations are resistant to damage (1, 2) . For instance, up to 90% of neurons in the corpus striatum may be deleted, but neurons that stain for NADPH diaphorase are relatively preserved (3, 4) . The discovery that NADPH diaphorase staining reflects neuronal nitric oxide synthase (nNOS) indicated that some property of nitric oxide synthase (NOS) neurons affords protection against neurotoxic mechanisms in HD (5) (6) (7) . Various mechanisms have been proposed to account for the neuronal destruction in HD, including excitotoxicity elicited by glutamate and free radical damage (8) (9) (10) (11) . Excitotoxic damage by glutamate involving N-methyl-D-asparate receptors appears to involve the release of NO, as NOS inhibitors block excitotoxic neuronal damage (12, 13) . Excitotoxic neuronal loss is also greatly diminished in mice with targeted disruption of the gene for nNOS (14) .
Huntingtin is the protein encoded by IT-15, the gene whose expanded CAG repeats account for HD (15) . Huntingtin occurs in numerous organs throughout the body and the brain with no discrete localizations that correspond to the selective neuropathology of HD (16) (17) (18) (19) . Recently, we identified a huntingtin-associated protein (HAP1) that is localized exclusively in the brain (20) . HAP1 binds to huntingtin in the region of the glutamine repeats, and the extent of binding parallels their expansion, whose length is associated with the age of onset of the disease, especially for juvenile-onset individuals with 60 or more CAG repeats (21) (22) (23) (16) . Tissue homogenate was centrifuged for 10 min at 800 x g to produce a pellet (P1). The supernatant (S1) was centrifuged at 9200 x g for 15 min to produce a pellet and a supernatant (S2). The pellet was washed by resuspension in the original volume of homogenization buffer and centrifugation for 15 min at 10,000 x g (P2). S2 was centrifuged at 165,000
x g for 2 hr to give pellet (P3) and soluble (S3) fractions. The P2 fraction was resuspended in a small volume of buffered sucrose and hypotonically lysed by addition of 9 vol of ice-cold water containing the above protease inhibitors and homogenization in a glass-Teflon homogenizer (three strokes). The P2 3) and processed as described above. Antibodies for glutathione S-transferase (GST)-rHAP1 (1 ,ug/ml) were affinity purified with Affi-Gel 15 (Bio-Rad) linked with immunogen, the GST-HAP1 fusion protein that was produced and purified as described (20) . Antibodies for nNOS (1:1000 dilution) were obtained from Transduction Laboratories. ABC and DAB detecting kits (Vector Laboratories) or immunofluorescence was used to visualize immunoreactive signals.
RESULTS
We conducted in situ hybridization to localize mRNA for HAP1 and nNOS in rat brain ( Fig. 1; Table 1 ). HAP1 localizations are strikingly discrete. The most intense message expression occurs in the accessory olfactory bulb and the pedunculopontine nuclei. The olfactory bulb itself also has high expression of message. In the hypothalamus, the supraoptic nucleus is intensely labeled. Substantial expression occurs in the basal forebrain, including the islands of Calleja, as well as in the dentate gyrus of the hippocampus, with much less labeling in CA1-3 layers. The superior and inferior colliculi are intensely labeled. Within the inferior colliculus, superficial layers are most intensely labeled, with negligible labeling in the central portion. In the cerebellum, light labeling is evident in the granule cell and Purkinje cell layers. In the lower brain stem, the nucleus of the tractus solitarius displays substantial labeling.
High power magnifications reveal that HAP1 silver grains are exclusively associated with neurons with no labeling of glia (Fig. 2) . In the corpus striatum, labeling occurs in scattered neurons in contrast to the accessory olfactory bulb where virtually all neurons appear to be heavily labeled. Within the cerebral cortex and dentate gyrus almost all neurons also are labeled.
The HAP1 localizations are similar in many brain regions to those of nNOS mRNA and protein (5, 24, 25) and in the present study using NADPH diaphorase staining ( Fig. 1 ; Table  1 ). The pedunculopontine nuclei, the supraoptic nucleus of the HAPI nNOS FIG. 1 . Similar localizations of HAP1 and nNOS mRNA expression in many regions of rat brain. A dark-field image of a sagittal section of adult rat brain shows strong labeling for HAP1 in olfactory bulb (OB), accessory olfactory bulb (AOB), dentate gyrus of the hippocampus (DG), superior and inferior colliculi (C), pedunculopontine nucleus (PPN), and supraoptic nucleus (SO). Moderate labeling occurs in cerebral cortex (Cx) and cerebellum (CB). nNOS mRNA expression in rat brain was detected as described (5) . NADPH diaphorase staining reveals the strongest labeling in OB, AOB, PPN, SO, and CB. Labeling is also evident in C and DG. A comparison of mRNA expression patterns for HAPI and nNOS is shown in Table 1. hypothalamus, and the accessory olfactory bulb are the most intensely labeled structures for nNOS mRNA. The olfactory bulb is also heavily labeled. Within the hippocampus, the dentate gyrus displays substantially more label than layers CA1-3. Immunohistochemistry and in situ hybridization have established the superior and inferior colliculi as sites with intense nNOS labeling most prominent in the superficial rather than central zones (5) . Discrepancy between HAP1 and nNOS occurs in the cerebellum, where granule cell layers are intensely labeled for nNOS, while HAP1 levels are less prominent (data not shown). Also, in normal rats the Purkinje cells do not display nNOS mRNA or protein (5, 6) . In the cerebral cortex and basal forebrain, neuronal labeling for nNOS is substantially more scattered than for HAP1.
To study the distribution of HAP1 protein, we conducted Western blot analysis of monkey and human brain regions Data are presented as relative intensity of hybridization based on our present study and previous studies (5, 24, 25) .
using an antibody generated against a HAP1 fusion protein (Fig. 3) . Whereas in rat brain three immunoreactive bands are evident (20) , in monkey and in human a single prominent band at 68 kDa occurs in all brain regions (though in monkey cortex a less intense band of about 46 kDa is also evident). We observe marked regional variations. In monkey brain intense bands occur in the cerebral cortex and hippocampus, whereas immunoreactivity is barely detectable in the pons and medulla. The vagus nerve, lung, adrenal, skeletal muscle, and spleen lack immunoreactivity, confirming our earlier observations that HAP1 is a brain-specific protein (20) . In human brain the hippocampus and caudate display the most intense labeling, whereas levels in the cerebral cortex and cerebellum are somewhat lower and no labeling occurs in thalamus or white matter.
Immunohistochemistry confirms the neuronal localizations of HAP1 (Fig. 4) . In monkey brain, negligible staining occurs in white matter, while the cerebral cortex and corpus striatum display substantial immunoreactivity, with higher levels of staining in caudate than cerebral cortex. In the striatum, a larger proportion of neurons display protein immunoreactivity than display mRNA. No staining is evident in sections preabsorbed with antigen.
We compared the subcellular localization of huntingtin, HAP1, and nNOS using a differential centrifugation procedure (Fig. 5) . In this procedure, a crude nuclear fraction (P1) is obtained by centrifugation at 800 x g for 10 min, and the supernatant is centrifuged at 10,000 x g for 15 min to provide a P2 fraction, whose supernatant is centrifuged at 165,000 x g for 2 hr, yielding P3 pellet and the soluble supernatant (S3) fraction. The P2 fraction contains primarily mitochondria and synaptosomes. After hypotonic lysis of P2, we obtain an LP1 pellet by centrifugation at 25,000 x g for 20 min, while centrifugation of the supernatant of this fraction at 165,000 x g for 2 hr provides the LP2 pellet and the soluble supernatant LS2 fraction.
As previously reported, huntingtin is present in both soluble and particulate fractions. Thus, equal densities are evident in LP2 and LS2 fractions. This contrasts with synaptophysin, a protein localized to membranes of synaptic vesicles, which is highly enriched in LP2 and not evident in LS2. Like synaptophysin, HAP1 is exclusively particulate and not evident in S3 or LS2 but heavily enriched in LP2. nNOS distribution closely resembles that of HAP1 except for the occurrence of some nNOS in the soluble fractions S3 and LS2, corresponding to the known occurrence of nNOS in cytoplasmic fractions (26) . Both HAP1 and nNOS are most enriched in LP2.
To further explore the intracellular distribution of HAP1, we examined its localization by immunohistochemistry in HEK 293 cells transfected with HAP1 (Fig. 6a) and in NIE115 cells that possess endogenous HAP1 (Fig. 6c) . In both cell types, HAP1 does not occur in the nucleus and does not appear to be selectively associated with the plasma membrane. Rather, it is concentrated in granular elements scattered throughout the cytoplasm. In monkey striatum, scattered large neurons in the corpus striatum contain greater densities of HAP1 immunoreactivity than medium-sized neurons (Fig. 6d) . In these _40P *0 -*--38 Synaptophysin FIG. 5. Subcellular localization of HAPI in monkey cerebral cortex extracts. Fractions are marked as H, homogenate, and P1, P2, S3, P3, LP1, LS2, and LP2, which are described in the text. A blot was probed with antibodies for huntingtin, nNOS, HAP1, and synaptophysin.
large neurons, we also observe granular HAP1 immunoreactivity with a cytoplasmic distribution and no association with the nucleus or plasma membrane (Fig. 6e) . Double labeling of the monkey striatum with NADPH diaphorase staining for nNOS (5-7) and antibodies for HAP1 shows that some large neurons labeled with antibodies against HAP1 are also labeled by staining for NADPH diaphorase. Some medium-sized neurons are also double labeled. The products of double labeling are predominantly in the cytoplasmic region ( Fig. 6f  and g ). More neurons display HAP1 than diaphorase staining.
DISCUSSION
In the present study, we confirm our earlier finding that HAP1 occurs exclusively in the brain. We also show that it is selectively associated with neurons. The major finding is that the localization of HAP1 resembles that of nNOS. The most prominent localizations of both HAP1 and nNOS mRNA are the accessory olfactory bulb and the pedunculopontine nuclei, with dense labeling in the olfactory bulb, supraoptic nucleus, and nucleus of the tractus solitarius. The concatenation of structures enriched in HAP1 and nNOS is unusual. However, their localizations are not identical. In the basal forebrain and At a cellular level, HAP1 has been detected in neuronal cells and some fiber extensions. HAP1 appears to be associated with granular structures that occur in the cytoplasm. The subcellular localization of HAP1 in the LP2 fraction could reflect an association with synaptic vesicles or cytoskeletal elements. This would fit with evidence for an association of huntingtin with the cytoskeleton and with synaptic vesicles (16) (17) (18) (19) . Double labeling of neurons with NADPH diaphorase and HAP1 indicates colocalizations of nNOS and HAP1 in the cytoplasm of a subpopulation of neurons.
The relationship between HAP1 and nNOS might be relevant to the pathophysiology of HD. A variety of evidence suggests that neuronal loss in HD is due to excitotoxic damage (8) (9) (10) (11) . Intrastriatal injections of malonate and systemic administration of 3-nitropropionic acid (3-NP) produce striatal lesions that closely resemble the histologic, neurochemical, and clinical features of HD and involve excitotoxic mechanisms consequent to energetic disturbances (29) (30) (31) (32) (33) . Excitotoxic neuronal loss caused by these toxins is greatly diminished in mice with a targeted disruption of the gene for nNOS or treated with 7-nitroindazole, a selective nNOS inhibitor (14, 34) . Thus, neuronally derived NO may participate in the pathophysiology of HD.
The possible relationship of nNOS with HAP1 is reminiscent of the association of nNOS and dystrophin (35) . Dystrophin is an extremely large cytoskeletal protein of skeletal muscle, whose mutation is responsible for the symptoms of Duchenne muscular dystrophy (36, 37) . Subcellular fractionation reveals an intimate association of nNOS and dystrophin (35, 38) . Dystrophin or one of its associated proteins is responsible for the predominantly particulate localization of nNOS in skeletal muscle. Thus, in mdx mice, which lack dystrophin, nNOS is fully soluble, and in human muscular dystrophy, nNOS is depleted from skeletal muscle (35) . A relationship between NO and the symptoms of muscular dystrophy is further suggested by the selective involvement of fast skeletal muscle fibers in the disease process and the selective association of nNOS with the fast fibers (39, 40) .
By analogy with the dystrophin-nNOS link, there may exist a complex of huntingtin, HAP1, and nNOS in certain neurons in the brain. nNOS is present only in a subpopulation of HAP1 neurons. Similarly, HAP1 is present only in a subpopulation of huntingtin-containing neurons. There is evidence for association of huntingtin with a protein complex that includes calmodulin (41) . Calmodulin is also involved in the regulation of nNOS (42) . In HD, it is conceivable that interactions among these proteins are altered. We have already established that HAP1 binds more avidly to mutated than to.wild-type huntingtin (20) . Perhaps as a result of altered interactions among these proteins, NO production is increased or occurs in aberrant intracellular sites, facilitating neuronal damage.
